Ashwagandha — upstream cortisol reduction
Mechanism: Ashwagandha (Withania somnifera) modulates the HPA axis — the pathway that translates psychological stress into cortisol release. Clinical trials show 15–30% cortisol reduction in stressed adults, with significant improvements in perceived stress and anxiety scores.
In the stress gastritis context: By reducing cortisol output, ashwagandha reduces the activation intensity of all four gastric damage mechanisms. Less cortisol → less COX suppression → less prostaglandin depletion → less mucus thinning. Less cortisol → less parietal cell stimulation → less acid excess.
What ashwagandha doesn't do: It doesn't repair the mucosal damage already accumulated from prior stress episodes. The thinned mucosa, the residual NF-kB inflammation, and the EGFR/ERK repair deficit persist until actively addressed by downstream mucosal repair support.
Verdict: Prevention/reduction tool. Strongest contribution for patients managing ongoing chronic stress. Less relevant for acute post-stress mucosal repair.
Antacids — M2 acid symptom relief
Antacids (calcium carbonate, Eno, Gelusil) neutralise the excess gastric acid that cortisol's parietal cell stimulation produces. Genuine symptomatic relief for acid-related burning — 15–30 minutes of neutralisation. M2 addressed; M1, M3, M4 not addressed. Appropriate for acute relief alongside a more complete mucosal support approach.
Probiotics — dysbiosis support
Sustained cortisol suppresses the SCFA-producing commensals that maintain microbiome stability — shifting toward gas-producing gram-negatives. Probiotics (Lactobacillus, Bifidobacterium) counteract this shift. Appropriate for stress-related bloating and altered transit. They do not address mucosal inflammation, NF-kB, or EGFR/ERK repair directly.
Flavonoid mucosal support — the most mechanism-complete approach
NF-kB inhibition (quercetin — M4): Inhibits NF-kB via IκB stabilisation, reducing the inflammatory cytokine cascade that cortisol drives through GR signalling and ROS. Reduces IL-6, IL-8, TNF-α production.
ROS attenuation (quercetin — M3): Quercetin's antioxidant activity directly scavenges reactive oxygen species — addressing the M3 mechanism that antioxidant defence collapse creates.
EGFR/ERK repair activation (glabridin — M4): Directly activates mucosal cell regeneration, rebuilding the mucosal barrier thinned by prostaglandin depletion (M1) and ROS damage (M3). 60–90 day repair cycle.
H. pylori urease inhibition (quercetin + myricetin): In patients where H. pylori is co-present, reduces urease activity and ammonia-mediated mucosal damage — particularly relevant in India's 62% H. pylori-positive symptomatic population.
The complete protocol
Addresses M3 (ROS via quercetin antioxidant activity), M4 (NF-kB inhibition via quercetin + EGFR/ERK repair via glabridin). Does not reduce cortisol upstream — works on the downstream mucosal damage cortisol produces.
Reduces cortisol 15–30% in stressed adults. Reduces activation intensity of all four damage mechanisms. Best used alongside mucosal repair support — reduces the ongoing trigger while TumGard addresses the existing damage.
In India's 62% H. pylori-positive symptomatic population, managing stress-related gastritis without H. pylori testing produces partial recovery. H. pylori maintains independent NF-kB activation between stress episodes — meaning the stomach remains inflamed even when cortisol normalises. H. pylori testing and treatment should precede or accompany any stress gastritis management protocol for patients with chronic or recurring symptoms.
References
- Chandrasekhar K et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root. Indian Journal of Psychological Medicine. 2012;34(3):255–262. PMID 23439798. Ashwagandha 15–30% cortisol reduction evidence — the primary evidence base for the adaptogens section of this guide.
- Ye YN et al. Licorice flavonoids and gastric mucosal repair via EGFR/ERK pathway. Journal of Ethnopharmacology. 2023;302:115866. PMID 36842733. Glabridin EGFR/ERK activation — M4 repair mechanism for stress-induced mucosal damage.
- Xiao ZP et al. Quercetin as inhibitor of H. pylori urease and NF-kB pathway. European Journal of Medicinal Chemistry. 2006;41(4):476–82. PMID 16887239. Quercetin NF-kB inhibition — M4 inflammatory mechanism from cortisol GR and ROS signalling.
- Merlin Annie Raj, RD. TumGard India Gut Health Report 2026. Hugg Beverages Pvt. Ltd. 2026. tumgard.com/india-gut-health-report-2026. 62% H. pylori positivity in symptomatic tested Indians — the India-specific context requiring H. pylori exclusion before stress attribution.